Navigation Links
Orchid Cellmark Reports Fourth Quarter and Full Year 2007 Financial Results
Date:3/6/2008

erating cost efficiencies, partially offset by reduced gross margin contribution associated with the reduced U.K. agricultural testing services.

Total operating expenses, excluding cost of service revenue, for the fourth quarter of 2007 were $5.8 million compared to $6.3 million for the fourth quarter of 2006. Operating expenses, excluding cost of service revenue, decreased from $29.2 million in 2006 to $24.2 million in 2007. These declines were primarily due to a decline in U.S. general and administrative, marketing and sales, and restructuring expenses resulting from our continued focus on reducing expenses.

The company's operating loss for the fourth quarter of 2007 was $1.3 million, compared to an operating loss of $956 thousand for the fourth quarter of 2006. The operating loss for the full year of 2007 was $4.1 million compared to $12.0 million in 2006. The increase in operating loss for the fourth quarter of 2007 compared to the fourth quarter of 2006 was principally due to the reduction in gross margin for the quarter compared to the same period in 2006 partially offset by a reduction in operating expenses, primarily reduced general and administrative expenses. The $7.9 million decrease in the operating loss for the full year of 2007 compared to 2006 primarily reflects stronger gross margins for the full year of 2007 coupled with lower operating expenses.

Orchid Cellmark reported net income of $168 thousand, or $0.01 per share, for the fourth quarter of 2007, compared to a net income of $885 thousand, or $0.03 per share, for the fourth quarter of 2006. The net loss for the full year of 2007 was $3.0 million, or $(0.10) per share, compared to a net loss of $11.3 million in 2006, or $(0.45) per share. The fourth quarters of 2007 and 2006 include proceeds from the sale of state net operating losses of $1.1 million and $749 thousand, respectively, which are reflected as reductions of income tax expense in the respective quarters and which po
'/>"/>

SOURCE Orchid Cellmark Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Orchid Cellmark to Announce Fourth Quarter and Full Year 2007 Financial Results on March 6, 2008
2. Orchid Cellmark Appoints William J. Thomas Vice President and General Counsel
3. Orchid Cellmark Reports Third Quarter 2007 Financial Results
4. MDS Reports First Quarter 2008 Results
5. American Oriental Bioengineering Reports Fourth Quarter and Full Year 2007 Financial Results
6. Longs Drug Stores Corporation Reports Results for Fourth Quarter and Fiscal Year 2008
7. LeMaitre Vascular Reports Q4 2007 Revenue of $11.1 Million, a 27% Increase
8. MannKind Corporation Reports Fourth Quarter and Full Year 2007 Financial Results
9. Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2007 Results
10. Endocare Reports 2007 Annual and Fourth Quarter Financial Results
11. Folic Acid in the Food Supply Reduces Birth Defects, but May Cause Extra Cancers, Reports the Harvard Womens Health Watch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 2015 In March, 1% for the ... kick off a new campaign, “Know Your Source,” which calls ... and ambassadors in their quest for ingredient awareness and better ... of its members and partners, including King Arthur Flour, Good ... to raise awareness for food as an environmental issue, with ...
(Date:3/3/2015)... 2015 Dr. Michael Nochomovitz ... chief clinical integration and network development officer ... newly established role, Dr. Nochomovitz is responsible ... System physician enterprise, its integration within NewYork-Presbyterian ... Cornell Physicians. , Dr. Nochomovitz brings 17 ...
(Date:3/3/2015)... 2015 Daylight Savings Time may lead to ... has tips for parents. , Parents and their children may ... a.m. when they set their clocks forward one hour for ... day -- one hour earlier -- you will have already ... start thinking about “sleep hygiene” for their kids and teens ...
(Date:3/3/2015)... March 03, 2015 DePuy Pinnacle ... metal-on-metal version of the artificial hip system caused ... to move forward in the federal multidistrict litigation ... Texas. According to the most recent Master Case ... 2015, 7,350 Pinnacle hip replacement lawsuits are now ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 The ... better predict antidepressant treatment outcomes for patients with ... than any of the individual genes that comprise ... investigators from the Mayo Clinic and Assurex Health, ... , The proprietary technology of the GeneSight ...
Breaking Medicine News(10 mins):Health News:1% For the Planet Asks Consumers to “Know Your Source” 2Health News:Dr. Michael Nochomovitz to Lead Clinical Integration and Network Development for the NewYork-Presbyterian Healthcare System 2Health News:Dr. Michael Nochomovitz to Lead Clinical Integration and Network Development for the NewYork-Presbyterian Healthcare System 3Health News:Dr. Michael Nochomovitz to Lead Clinical Integration and Network Development for the NewYork-Presbyterian Healthcare System 4Health News:Don’t Let Daylight Savings Disrupt Your Child’s Sleep 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 3Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 4Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 2Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 3Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 4Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 5Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 6
... BKD ) announced today that it plans to release ... Wednesday, May 6, 2009. The Company has also scheduled a ... at 10:00 AM ET. The conference call can be accessed ... (from outside of the U.S.) ten minutes prior to the scheduled ...
... 30 The American Academy of Dermatology (Academy) today ... and Drug Administration,s (FDA) announcement that a box warning ... products and a medication guide will be distributed to ... are FDA-approved for the treatment of frown lines between ...
... International Scholarly Journals, Web of Science Can Identify Highly ... Perspective in the Face of the Current Swine Flu ... eb of Science is the world,s ... journals and 130,000 academic conferences from around the globe ...
... The battle for beauty now goes wrinkle-to-wrinkle, as ... expected to begin their challenge to Botox(R) sometime within ... the U.S. aesthetics market is sure to spark heated ... also between medical professionals soon to be promoting one ...
... drugs to encourage red blood cell formation (erythropoiesis-stimulating agents) ... death and serious adverse events such as blood clots, ... . , While the relative increased risk of death ... in cancer patients this increase might translate into significant ...
... (Nasdaq: BLUD ), a global leader in ... today announced that access to its presentation at the ... Conference in New York, NY will be available via ... scheduled for Tuesday, May 12, 2009, at 12:40 p.m. ...
Cached Medicine News:Health News:Brookdale Announces First Quarter 2009 Release and Earnings Call 2Health News:American Academy of Dermatology Responds to FDA Decision Regarding Botulinum Toxin Products 2Health News:Thomson Reuters Web of Science(R) Provides Insights Into More than a Century of Influenza Research for Today's Health Professionals 2Health News:Thomson Reuters Web of Science(R) Provides Insights Into More than a Century of Influenza Research for Today's Health Professionals 3Health News:Thomson Reuters Web of Science(R) Provides Insights Into More than a Century of Influenza Research for Today's Health Professionals 4Health News:New Botox(R) Alternative Dysport(TM) FDA Approved, Ready to Rumble 2Health News:New Botox(R) Alternative Dysport(TM) FDA Approved, Ready to Rumble 3Health News:Drugs to combat anemia in cancer patients increase risk of death 2
(Date:3/3/2015)... -- Today, the Partnership for Prescription Assistance (PPA), ... companies, unveiled a redesigned website with ... caregivers with faster, easier access to information on ... programs. Since its launch in ... educate and empower patients and caregivers to access ...
(Date:3/3/2015)... -- - CPhI and P-MEC China 2015 ... Shanghai, China - The 15th ... held at Shanghai New International Expo Center, on 24th June, ... Worldwide and was introduced to China in 2001. It has ... companies and global pharmaceutical industry over the past 15 years. ...
(Date:3/3/2015)... 3, 2015  Tru-D SmartUVC will exhibit the ... Perioperative Registered Nurses, Surgical Conference and Expo 2015 ... Patient Safety Awareness Week March 7 through 11. ... clinical practice and professional development. ... http://photos.prnewswire.com/prnh/20150302/178998LOGO   Tru-D SmartUVC,s ...
Breaking Medicine Technology:Partnership for Prescription Assistance Relaunches Website with New Features for Patients and Caregivers 215th Anniversary, Be Part of Chinese Pharma Dream 215th Anniversary, Be Part of Chinese Pharma Dream 3Tru-D SmartUVC to Exhibit Most Effective UV Disinfection Robot at AORN Surgical Conference and Expo 2015 2Tru-D SmartUVC to Exhibit Most Effective UV Disinfection Robot at AORN Surgical Conference and Expo 2015 3
... Jan. 26, 2012  Watson Pharmaceuticals, Inc. (NYSE: ... States Court of Appeals for the Federal Circuit ... for a stay of the preliminary injunction preventing ... Sodium Injection, a generic equivalent to Sanofi-aventis, LOVENOX®.  ...
... Inc. (Nasdaq: CRDC ) today announced that ... Proximal Anastomosis System during on- and off-pump coronary artery ... secure connection, or anastomosis, between a vein graft and ... during CABG procedures and was first shipped to Japan ...
Cached Medicine Technology:Watson Confirms Court Stays Preliminary Injunction 2Watson Confirms Court Stays Preliminary Injunction 3Cardica Achieves Key Milestone With Over 25,000 PAS-Port® Proximal Anastomosis Systems Deployed Worldwide 2
... M Tests are qualitative enzyme immunoassays (EIA) ... antibodies (IgG or IgM, respectively) in serum. ... should be supplemented with a standardized western ... used to support a clinical diagnosis of ...
The ImmunoWELL TPO IgG Quantitative Test is a quantitative enzyme immunoassay (EIA) for screening and detection of autoantibodies against human thyroid peroxidase (microsome) in serum and is used as ...
... The ImmunoWELL Cardiolipin Antibody (IgM) ... (EIA) for the quantitative detection ... in serum and is used ... the risk of thrombosis in ...
The miniSPO 2 T has the same advanced DOX digital technology as our multiple parameter vital signs monitors and lets you evaluate oxygen saturation and heart rate in a broad range of patients, from n...
Medicine Products: